<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31033" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Vasodilation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramanlal</surname>
            <given-names>Riddhi</given-names>
          </name>
          <aff>Lake Erie College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Riddhi Ramanlal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31033.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vasodilation is the widening of blood vessels due to the relaxation of the blood vessel's muscular walls. It is a mechanism to enhance blood flow to areas of the body lacking oxygen or nutrients. Vasodilation causes a decrease in systemic vascular resistance (SVR) and an increase in blood flow, reducing blood pressure.&#x000a0;</p>
      </sec>
      <sec id="article-31033.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Although vasodilation is a natural response necessary for our bodies, in specific scenarios, excessive vasodilation can cause harm:</p>
        <p>
<bold>Anaphylaxis</bold>
</p>
        <p>Severe anaphylactic shock occurs when a rapid release of inflammatory mediators and cytokines triggers widespread vasodilation and increased vascular permeability. This situation leads to activating the inflammatory cascade, and immediate epinephrine is the first-line treatment.<xref ref-type="bibr" rid="article-31033.r1">[1]</xref></p>
        <p>
<bold>Septic Shock</bold>
</p>
        <p>Vasodilation is a normal response during inflammatory processes to increase blood flow to affected areas. However, in response to overwhelming infection, our bodies release numerous vasodilatory chemicals that cause inflammation and can lead to lethal hypotension.<xref ref-type="bibr" rid="article-31033.r2">[2]</xref></p>
      </sec>
      <sec id="article-31033.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Endothelial cells form the lining of blood vessels. These cells have the critical ability to rearrange and remodel the vasculature network. This feature of endothelial cells enables blood vessel changes and adequate blood flow to allow tissue growth and repair throughout the body. The endothelial cells are closest to the lumen of both arteries and veins. Surrounding the thin endothelial cell layer is a basal lamina, followed by varying amounts of smooth muscle cells and connective tissue dependent on the vessel&#x02019;s function. In contrast to arteries and veins, capillaries are only a single layer of endothelial cells and pericytes.<xref ref-type="bibr" rid="article-31033.r3">[3]</xref></p>
      </sec>
      <sec id="article-31033.s4" sec-type="Development">
        <title>Development</title>
        <p>Arteries and veins develop from initially small vessels composed&#x000a0;of endothelial cells. The remaining components of the blood vessel lining are subsequently added upon signaling from the endothelial cells. Endothelial cells have mechanoreceptors that can sense stress. These allow the endothelial cells to signal the surrounding cells to produce connective tissue and smooth muscle adaptations to decrease stress and better accommodate the blood flow. If an area of the vascular system is damaged, the endothelial cells can undergo cell division and proliferate to repair areas.&#x000a0;</p>
        <p>Angiogenesis is the process of new blood vessel formation. It occurs as a response to signaling from endothelial cells in an existing blood vessel. The most notable signals are vascular endothelial growth factor (VEGF) and fibroblast growth factor family (FGF).<xref ref-type="bibr" rid="article-31033.r4">[4]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31033.s5" sec-type="Organ Systems Involved">
        <title>Organ Systems Involved</title>
        <p>Vasodilation affects all organ systems in the body. It increases blood flow to tissues throughout the body.</p>
      </sec>
      <sec id="article-31033.s6" sec-type="Function">
        <title>Function</title>
        <p>Vasodilation increases blood flow to the body's tissues. In response to a need for oxygen or nutrients, tissues can release endogenous vasodilators. The result is a decrease in vascular resistance and an increase in capillary perfusion. A common example of this vasodilation response occurs during exercise. When exercising, the oxygen consumption by skeletal muscles rapidly increases, and it is necessary to increase the oxygen supply.</p>
      </sec>
      <sec id="article-31033.s7" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Vasodilation occurs when the smooth muscle located in the blood vessel walls relaxes. Relaxation can be due to either removing a contractile stimulus or inhibiting contractility. Numerous stimuli, including acetylcholine, ATP, adenosine, bradykinin, histamine, and shear stress, can activate eNOS and COX pathways that form nitric oxide (NO) and prostacyclin, respectively.&#x000a0;Nitric oxide&#x000a0;and prostacyclin produced within endothelial cells utilize intracellular secondary messengers.&#x000a0;Nitric oxide&#x000a0;primarily uses cyclic guanosine monophosphate (cGMP) for cellular effects, whereas prostacyclin effects are primarily mediated by cyclic adenosine monophosphate (cAMP).<xref ref-type="bibr" rid="article-31033.r5">[5]</xref>&#x000a0;These secondary messengers produced in the smooth muscle cells have downstream effects of causing a decrease in intracellular&#x000a0;Ca and an increase in myosin light chain (MLC) phosphatase activity. In smooth muscle cells, active MLC phosphatase dephosphorylates the contracted actin and MLC complex, causing MLC to relax. Intracellular cations are removed by Ca and Mg-ATPases that sequester Ca back into the sarcoplasmic reticulum. Na/Ca antiporters in the plasma membrane can also decrease intracellular&#x000a0;Ca. During relaxation, receptor-gated and voltage-gated Ca channels inhibit&#x000a0;Ca entry into the smooth muscle cell.<xref ref-type="bibr" rid="article-31033.r6">[6]</xref>&#x000a0;The overall effect is the relaxation of the smooth muscle, which causes vasodilation.&#x000a0;</p>
        <p>Other mediators involved in vasodilation are generated during enhanced muscle activity. These stimuli include&#x000a0;pCO<sub>2</sub>, lactate,&#x000a0;K, and adenosine. Venous&#x000a0;pCO<sub>2</sub> levels increase during exercise due to the high turnover of the Krebs cycle to meet the oxygen demands of skeletal muscle. A net gain in lactic acid is produced by exercising muscle due to increased glycolysis activity. Skeletal muscle cells release&#x000a0;K ions into the interstitium during an action potential. During exercise, there is also an increase in the breakdown of adenosine triphosphate (ATP), yielding adenosine. The above mediators produced can diffuse to adjacent arterioles and have powerful vasodilatory effects, increasing the oxygen and nutrient supply to exercise muscle when demand is enhanced.<xref ref-type="bibr" rid="article-31033.r7">[7]</xref></p>
      </sec>
      <sec id="article-31033.s8" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>Myocardial perfusion testing is a noninvasive diagnostic evaluation performed on suspected coronary artery disease patients. Pharmacological stimuli, most commonly adenosine, assess myocardial blood flow and coronary flow reserve. Adenosine is a powerful vasodilator used in these tests to produce maximal hyperemia during imaging.<xref ref-type="bibr" rid="article-31033.r8">[8]</xref>&#x000a0;Acute vasodilator testing can help to identify patients with pulmonary artery hypertension (PAH) who may respond to calcium channel blocker therapy. The testing procedure is performed during a right-heart catheterization. Vasodilatory medications are administered to assess the ability of the pulmonary arteries to relax before and after administration. Commonly used vasodilator drugs for the procedure include nitric oxide, epoprostenol, and adenosine.<xref ref-type="bibr" rid="article-31033.r9">[9]</xref></p>
      </sec>
      <sec id="article-31033.s9" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>While multiple mechanisms can contribute to shock,&#x000a0;1 of the most common is distributive shock. Distributive shock characteristically demonstrates widespread peripheral vasodilation caused by vascular smooth muscle reactivity loss.<xref ref-type="bibr" rid="article-31033.r10">[10]</xref>&#x000a0;The vasodilation causes hypotension with resulting tissue hypoperfusion. Patients with septic shock, a type of distributive shock, often have elevated levels of catecholamines. The body releases the catecholamines as endogenous vasoconstrictors but cannot elicit an appropriate pressure response in the pathologic shock state. Additionally, endothelial cells can overexpress nitric oxide, contributing to even more pronounced vasodilation.<xref ref-type="bibr" rid="article-31033.r11">[11]</xref>&#x000a0;Management of this vasodilatory shock requires fluid resuscitation and the initiation of norepinephrine, a potent vasopressor. If this therapy is refractory, other vasopressors, such as vasopressin and epinephrine, can be added.<xref ref-type="bibr" rid="article-31033.r2">[2]</xref></p>
      </sec>
      <sec id="article-31033.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Hypertension is the term for elevated blood pressure. More specifically, a systolic blood pressure &#x02265;130&#x02009;mmHg or a diastolic pressure &#x02265; 80&#x02009;mmHg. Numerous medication classes are in clinical use to reduce high blood pressure by promoting vasodilation:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Calcium Channel Blockers: Block Ca<sup>2+</sup> ions influx into vascular smooth muscle and cardiac muscle. The inhibition of Ca<sup>2+</sup> leads to the relaxation of the vascular muscle cells and, therefore, vasodilation. These are primarily used to treat hypertension and angina.<xref ref-type="bibr" rid="article-31033.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Nitrates: Utilize secondary messengers that cause downstream effects of smooth muscle relaxation. Nitroglycerin is a nitrate most commonly used to relieve angina attacks.<xref ref-type="bibr" rid="article-31033.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Angiotensin-Converting Enzyme Inhibitors: Prevent the production of angiotensin II and inhibit the breakdown of bradykinin. Angiotensin II normally decreases NO production, and bradykinin stimulates NO release. The combined effects lead to increased NO, which causes vasodilation and can be used to lower blood pressure.<xref ref-type="bibr" rid="article-31033.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31033.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31033&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31033">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31033/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31033">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31033.s12">
        <title>References</title>
        <ref id="article-31033.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kr&#x0010d;mov&#x000e1;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Novosad</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Anaphylactic symptoms and anaphylactic shock].</article-title>
            <source>Vnitr Lek</source>
            <year>2019</year>
            <season>Winter</season>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-156</page-range>
            <pub-id pub-id-type="pmid">30909706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jentzer</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Vallabhajosyula</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Busse</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Kashani</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Management of Refractory Vasodilatory Shock.</article-title>
            <source>Chest</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>154</volume>
            <issue>2</issue>
            <fpage>416</fpage>
            <page-range>416-426</page-range>
            <pub-id pub-id-type="pmid">29329694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kr&#x000fc;ger-Genge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blocki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Vascular Endothelial Cell Biology: An Update.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Sep</month>
            <day>07</day>
            <volume>20</volume>
            <issue>18</issue>
            <pub-id pub-id-type="pmid">31500313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulanger</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Endothelium.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>e26</fpage>
            <page-range>e26-31</page-range>
            <pub-id pub-id-type="pmid">27010027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hellsten</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nyberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Mortensen</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Vasodilator interactions in skeletal muscle blood flow regulation.</article-title>
            <source>J Physiol</source>
            <year>2012</year>
            <month>Dec</month>
            <day>15</day>
            <volume>590</volume>
            <issue>24</issue>
            <fpage>6297</fpage>
            <page-range>6297-305</page-range>
            <pub-id pub-id-type="pmid">22988140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Webb</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Smooth muscle contraction and relaxation.</article-title>
            <source>Adv Physiol Educ</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>1-4</issue>
            <fpage>201</fpage>
            <page-range>201-6</page-range>
            <pub-id pub-id-type="pmid">14627618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarelius</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pohl</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Control of muscle blood flow during exercise: local factors and integrative mechanisms.</article-title>
            <source>Acta Physiol (Oxf)</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>199</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-65</page-range>
            <pub-id pub-id-type="pmid">20353492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knaapen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Optimal Vasodilation Protocols: The Devil Is in the Details.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28213450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Obiagwu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mezue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haythe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Einstein</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Role of Vasodilator Testing in Pulmonary Hypertension.</article-title>
            <source>Prog Cardiovasc Dis</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>425</fpage>
            <page-range>425-33</page-range>
            <pub-id pub-id-type="pmid">26434988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Circulatory shock.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Oct</month>
            <day>31</day>
            <volume>369</volume>
            <issue>18</issue>
            <fpage>1726</fpage>
            <page-range>1726-34</page-range>
            <pub-id pub-id-type="pmid">24171518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rush</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of Septic Shock.</article-title>
            <source>Crit Care Clin</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-61</page-range>
            <pub-id pub-id-type="pmid">29149941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <chapter-title>Calcium Channel Blockers</chapter-title>
            <source>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</source>
            <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2017</year>
            <month>1</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">31643892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarkin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kaski</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Vasodilator Therapy: Nitrates and Nicorandil.</article-title>
            <source>Cardiovasc Drugs Ther</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-378</page-range>
            <pub-id pub-id-type="pmid">27311574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31033.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ancion</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tridetti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nguyen Trung</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Oury</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril.</article-title>
            <source>Cardiol Ther</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-191</page-range>
            <pub-id pub-id-type="pmid">31578675</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
